Literature DB >> 28565809

Clinical study on the association between pregnancy-induced hypertension and insulin resistance.

Zhifang Chen1, Weiling Liu1, Xiaoqin Sun1, Lingling Zhu1.   

Abstract

The aim of the present study was to explore the association between pregnancy-induced hypertension (PIH) and insulin resistance (IR). A total of 50 cases of PIH and 50 healthy pregnant women with a similar gestational age were enrolled. The hyperinsulinemic-euglycemic clamp technique was used to evaluate the degree of IR and all 100 subjects were divided into an IR and a non-IR group accordingly. Subsequently, the correlation between the systolic or diastolic blood pressure was assessed; furthermore, a homeostasis model assessment of IR (HOMA-IR), a HOMA of the insulin sensitivity index (HOMA-ISI) and a HOMA of β cell function (HOMA-β%) were performed. Moreover, the effect of IR on PIH was assessed and the protein expression of insulin receptor substrate (IRS)-1, phosphorylated (p)-IRS-1, AKT and p-AKT were detected in the placental plasma by western blot analysis. The results showed that in the PIH group, the p-IRS-1/IRS-1 and p-AKT/AKT ratios were decreased compared with those in the control group. Blood flow parameters, including perfusion index, retinal resistive index and systolic maximum velocity/end-diastolic velocity ratio in the IR group were higher, while time averaged velocity was lower compared with that in the non-IR group. Furthermore, the HOMA-ISI and HOMA-β% were decreased, while the HOMA-IR was increased in the PIH group compared to that in the control group; alongside the blockage of the insulin signaling pathway, these factors may therefore cause PIH. The present study may provide novel therapeutic approaches for PIH.

Entities:  

Keywords:  HOMA-IR; HOMA-ISI; HOMA-β%; insulin resistance; pregnancy-induced hypertension

Year:  2017        PMID: 28565809      PMCID: PMC5443191          DOI: 10.3892/etm.2017.4169

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  27 in total

1.  Does maternal asthma contribute to racial/ethnic disparities in obstetrical and neonatal complications?

Authors:  Katrina F Flores; Candace A Robledo; Beom Seuk Hwang; Kira Leishear; Katherine Laughon Grantz; Pauline Mendola
Journal:  Ann Epidemiol       Date:  2015-01-30       Impact factor: 3.797

2.  Risk estimation of metabolic syndrome at one and three years after a pregnancy complicated by preeclampsia.

Authors:  Graeme N Smith; Jessica Pudwell; Mark Walker; Shi-Wu Wen
Journal:  J Obstet Gynaecol Can       Date:  2012-09

3.  In preeclampsia, maternal third trimester subcutaneous adipocyte lipolysis is more resistant to suppression by insulin than in healthy pregnancy.

Authors:  Shahzya S Huda; Rachel Forrest; Nicole Paterson; Fiona Jordan; Naveed Sattar; Dilys J Freeman
Journal:  Hypertension       Date:  2014-03-03       Impact factor: 10.190

4.  Elevated serum angiopoietin-like protein 6 in women with subsequent pregnancy-induced hypertension: a preliminary study.

Authors:  Anna L Tuuri; Matti S Jauhiainen; Christian P Ehnholm; Matti J Tikkanen; M Gary Nicholls; Risto J Kaaja
Journal:  Hypertens Pregnancy       Date:  2013-08       Impact factor: 2.108

5.  Assessment of pregestational insulin resistance as a risk factor of preeclampsia.

Authors:  Enrique Valdés; Alvaro Sepúlveda-Martínez; Bárbara Manukián; Mauro Parra-Cordero
Journal:  Gynecol Obstet Invest       Date:  2014-01-25       Impact factor: 2.031

6.  Increased plasma norepinephrine levels in previously pre-eclamptic women.

Authors:  K H Lampinen; M Rönnback; P-H Groop; M G Nicholls; T G Yandle; R J Kaaja
Journal:  J Hum Hypertens       Date:  2013-09-19       Impact factor: 3.012

Review 7.  The putative metabolic role of d-chiro inositol phosphoglycan in human pregnancy and preeclampsia.

Authors:  Marco Scioscia; Marilena Nigro; Monica Montagnani
Journal:  J Reprod Immunol       Date:  2013-08-02       Impact factor: 4.054

Review 8.  Insulin resistance and dysregulation of tryptophan-kynurenine and kynurenine-nicotinamide adenine dinucleotide metabolic pathways.

Authors:  Gregory Oxenkrug
Journal:  Mol Neurobiol       Date:  2013-06-28       Impact factor: 5.590

9.  Two-hour insulinemia after oral glucose overload and women at risk of pregnancy-induced hypertensive disorders.

Authors:  José Romero; Eduardo Spinedi
Journal:  Hypertens Pregnancy       Date:  2013-07-11       Impact factor: 2.108

10.  Estimating rate of insulin resistance in patients with preeclampsia using HOMA-IR index and comparison with nonpreeclampsia pregnant women.

Authors:  Farideh Rezaei Abhari; Maryam Ghanbari Andarieh; Asadollah Farokhfar; Soleiman Ahmady
Journal:  Biomed Res Int       Date:  2014-04-09       Impact factor: 3.411

View more
  3 in total

1.  Physiological subtypes of gestational glucose intolerance and risk of adverse pregnancy outcomes.

Authors:  Daryl J Selen; P Kaitlyn Edelson; Kaitlyn James; Kathryn Corelli; Marie-France Hivert; James B Meigs; Ravi Thadhani; Jeffrey Ecker; Camille E Powe
Journal:  Am J Obstet Gynecol       Date:  2021-08-19       Impact factor: 10.693

2.  Blood glucose related to pregnancy induced hypertension syndrome.

Authors:  Zhao Zhou; Cuiyan Deng; Xuewen Xiang
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

3.  Incidence of maternal and fetal outcomes in women with gestational diabetes.

Authors:  Olfa Lajili; Yosra Htira; Aroua Temessek; Imen Hedfi; Sarra Ben Amara; Feika Ben Mami
Journal:  Tunis Med       Date:  2022 mars
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.